AZoLifeSciences on MSN1mon
High-throughput screening identifies potential drugs for low-grade serous ovarian cancer
Low-grade serous ovarian carcinoma (LGSOC) is a rare subtype of epithelial ovarian tumor, making it challenging to ...
eLife6d
Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer
Penn Ovarian Cancer Research Center and Basser Center for BRCA, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States ...
News Medical1mon
The threat of serous uterine cancer: A new perspective
As expected, the ovarian cancers looked like human high-grade serous ovarian cancer. "But they also clustered with this form of uterine cancer that we did not expect, so the uterine cancer cells ...
Business Wire1mon
Verastem Oncology Presents Positive Updated RAMP 201 Data for Avutometinib and Defactinib Combination in Recurrent Low-Grade Serous Ovarian Cancer at the International ...
“The notable response rates and low discontinuation ... a rare ovarian cancer that is insidious, persistent and ultimately fatal. LGSOC is distinct and different from high-grade serous ovarian ...
Team identifies origin of deadly ovarian cancer
More information: Andrea Flesken-Nikitin et al, Pre-ciliated tubal epithelial cells are prone to initiation of high-grade ...
Pharmabiz12d
Verastem Oncology submits NDA to US FDA for avutometinib plus defactinib to treat recurrent KRAS mutant low-grade serous ovarian cancer
There are currently no FDA-approved treatments specifically for LGSOC, a rare and distinct ovarian cancer that differs from high-grade serous ovarian ... for patients with recurrent KRAS mutant ...